Schedule 13D ownership disclosure

BELLEROPHON THERAPEUTICS INC

Security class unavailable · CUSIP: 078771300

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,153,846
Percent of class
12.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001718111-20-000003
Form type
SC 13D
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
May 22, 2020
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub